학술논문

DOP008 Safety of adalimumab in children and adolescents with moderate-to-severe Crohn’s disease: interim results of the CAPE registry
Document Type
Academic Journal
Source
Journal of Crohnʼs and Colitis. Feb 01, 2018 12(supplement_1 Suppl 1):S035-S035
Subject
Language
English
ISSN
1873-9946